⌘K

Login Start Free

Home/Filings/4/0001213900-23-019558

4//SEC Filing

Eliya Yehuda 4

Accession 0001213900-23-019558

CIK 0001415397other

View on SEC.gov Company Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 4:03 PM ET

Size

5.2 KB

Accession

0001213900-23-019558

Insider Transaction Report

Form 4

Period: 2022-12-05

Raphael Pharmaceutical Inc.RAPH

Director

Transactions

Award
Warrants to Purchase Common Stock
2022-12-05+202,000→ 202,000 total
Exercise: $1.12Exp: 2024-12-05→ Common Stock (202,000 underlying)

Footnotes (1)

[F1]The warrants are exercisable immediately.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Raphael Pharmaceutical Inc.

CIK 0001415397

Entity typeother

Related Parties

1

filerCIK 0001904163

Filing Metadata

Form type: 4
Filed: Mar 12, 8:00 PM ET
Accepted: Mar 13, 4:03 PM ET
Size: 5.2 KB

View on SEC.gov